Physiotherapy/hypnosis for AVC Patients
Launched by UNIVERSITY OF LIEGE · Mar 19, 2025
Trial Information
Current as of May 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The cerebrovascular accident (CVA) is a pathology generating many disabled people. Physiotherapy is one of the usual rehabilitation techniques for a patient with sequelae of ischemia or cerebral hemorrhage. Combined with another therapeutic approach, hypnosis, it could increase the patient's motor performance.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 to 80 years old
- • Having experienced a stroke more than 3 months ago
- • Understanding and proficient in the French language
- • Having a functional capacity deficit in at least one of the two upper limbs
- • Being able to independently travel to the Yerne medical center for necessary study appointments.
- Exclusion Criteria:
- • Being under 18 or over 80 years old
- • Having a history of upper limb injuries (fractures, prosthetics, etc.)
- • Having Wernicke's aphasia (language comprehension disorder)
- • Having frontal lobe syndrome
- • Undergoing chemotherapy
- • Having respiratory disorders (respiratory failure of more than 70%) or receiving oxygen therapy
- • Having epilepsy
- • Having dementia
- • Having untreated hearing impairments
- • Being diagnosed with schizophrenia or paranoïa
- • Experiencing significant concentration difficulties
About University Of Liege
The University of Liège, a prestigious research institution in Belgium, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and biomedical engineering, to conduct high-quality research aimed at improving patient outcomes. The institution fosters a rigorous ethical framework and adheres to international standards in clinical research, ensuring the integrity and reliability of its studies. Through its clinical trials, the University of Liège aims to contribute significantly to the development of novel therapeutic approaches and enhance the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liège, , Belgium
Patients applied
Trial Officials
Audrey Vanhaudenhuyse, PhD
Study Director
University of Liege
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported